SlideShare a Scribd company logo

Founder mutation in Parkinson's disease presented on 12/10/08

•
•
P
pcpchic

Based on paper by Nuytemans, K. & et. al. from European Journal of Human Genetics 16: 471-479.

TechnologyHealth & Medicine
1 of 20
Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson’s disease patients Presented by: Pearl Pfiester 12.10.08
LRRK2 Gene ,[object Object],[object Object],[object Object]
Why study LRRK2 Gene? ,[object Object],[object Object],[object Object],[object Object],[object Object]
Objective ,[object Object]
Signal Transduction ,[object Object],[object Object],[object Object],[object Object]
Subjects ,[object Object],[object Object],[object Object]
Gene Sequencing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Haplotype Analysis ,[object Object],[object Object],[object Object]
Results ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Results Reported and novel coding mutations in the LRRK2 Roc and kinase domains. Symbols: red stars = putative pathogenic missense mutations detected in the Flanders-Belgian PD population (6 out of 10 carriers) green stars = novel rare variants (4 out of 10 carriers) yellow stars = known polymorphisms
Data on protein conservation of all coding mutations in the LRRK2 Roc and kinase domains
Results for p.R1441C ,[object Object],[object Object]
Results ,[object Object],[object Object],[object Object]
Results for p.R1441C ,[object Object],[object Object],[object Object],[object Object],[object Object]
Results for p.R1441C
Results: Allele and Haplotype Analysis for p.R1441C
Results for Novel Mutations
Results for Novel Mutations
Conclusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 

Recommended

Mutation Lrrk2 Parkinson
Mutation Lrrk2 ParkinsonMutation Lrrk2 Parkinson
Mutation Lrrk2 Parkinson
laurentmagnies
 
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...
QIAGEN
 
Rna interference
Rna interferenceRna interference
Rna interference
pranatee behera
 
Rna silencing in plants
Rna silencing in plantsRna silencing in plants
Rna silencing in plants
shru1604
 
Non coding RNA & diseases
Non coding RNA & diseasesNon coding RNA & diseases
Non coding RNA & diseases
sepidehsaroghi
 
Final ppt 21
Final ppt 21Final ppt 21
Final ppt 21
RAVIKUMAR4847
 
Biotechnology:Gene Silencing And Editing
Biotechnology:Gene Silencing And EditingBiotechnology:Gene Silencing And Editing
Biotechnology:Gene Silencing And Editing
St Mary's College,Thrissur,Kerala
 
Creative biogene-The Extended Applications of RNAi
Creative biogene-The Extended Applications of RNAiCreative biogene-The Extended Applications of RNAi
Creative biogene-The Extended Applications of RNAi
creative biogene
 

Recommended

Mutation Lrrk2 Parkinson
Mutation Lrrk2 ParkinsonMutation Lrrk2 Parkinson
Mutation Lrrk2 Parkinson
laurentmagnies
 
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...
QIAGEN
 
Rna interference
Rna interferenceRna interference
Rna interference
pranatee behera
 
Rna silencing in plants
Rna silencing in plantsRna silencing in plants
Rna silencing in plants
shru1604
 
Non coding RNA & diseases
Non coding RNA & diseasesNon coding RNA & diseases
Non coding RNA & diseases
sepidehsaroghi
 
Final ppt 21
Final ppt 21Final ppt 21
Final ppt 21
RAVIKUMAR4847
 
Biotechnology:Gene Silencing And Editing
Biotechnology:Gene Silencing And EditingBiotechnology:Gene Silencing And Editing
Biotechnology:Gene Silencing And Editing
St Mary's College,Thrissur,Kerala
 
Creative biogene-The Extended Applications of RNAi
Creative biogene-The Extended Applications of RNAiCreative biogene-The Extended Applications of RNAi
Creative biogene-The Extended Applications of RNAi
creative biogene
 
Short hairpin rna
Short hairpin rna Short hairpin rna
Short hairpin rna
Nagendra P
 
Terra (Telomeric repeat-containing RNA)
Terra (Telomeric repeat-containing RNA)Terra (Telomeric repeat-containing RNA)
Terra (Telomeric repeat-containing RNA)
sogand vahidi
 
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
QIAGEN
 
RNA interference
RNA interferenceRNA interference
RNA interference
Razavi Nader
 
Gene silencing and rnai
Gene silencing and rnaiGene silencing and rnai
Gene silencing and rnai
shiney chatak
 
The Role of Astroglia in the Development of Down Syndrome
The Role of Astroglia in the Development of Down SyndromeThe Role of Astroglia in the Development of Down Syndrome
The Role of Astroglia in the Development of Down Syndrome
Kathleen Allyson Harrison
 
RNA interference (RNAi):A therapeutic strategy for aquaculture
RNA interference (RNAi):A therapeutic strategy for aquacultureRNA interference (RNAi):A therapeutic strategy for aquaculture
RNA interference (RNAi):A therapeutic strategy for aquaculture
idrish123
 
RNAi interuption mechanism and application
RNAi interuption mechanism and applicationRNAi interuption mechanism and application
RNAi interuption mechanism and application
Sumeena Karki
 
Regulatory RNA
Regulatory RNARegulatory RNA
Regulatory RNABhabani Panigrahy
 
RNA interference & its application
RNA interference & its applicationRNA interference & its application
RNA interference & its application
AkritiGaurav
 
Gene silencing
Gene silencingGene silencing
Gene silencing
Md. Dilshad karim
 
The future of treatments for PD psych research symposium poster 1_20162
The future of treatments for PD psych research symposium poster 1_20162The future of treatments for PD psych research symposium poster 1_20162
The future of treatments for PD psych research symposium poster 1_20162Morgan Stafford
 
RNA Interference (RNAi)
RNA Interference (RNAi)RNA Interference (RNAi)
RNA Interference (RNAi)
Suresh Antre
 
Hucis
HucisHucis
HucisFlavio Guzmán
 
Receptor targeted polyplexes for pdna and sirna delivery emadi
Receptor targeted polyplexes for pdna and sirna delivery emadiReceptor targeted polyplexes for pdna and sirna delivery emadi
Receptor targeted polyplexes for pdna and sirna delivery emadi
Elaheh Emadi- Andani
 
Rna and truncated form in health and diseases
Rna and truncated form in health and diseasesRna and truncated form in health and diseases
Rna and truncated form in health and diseases
Gaurav Gupta
 
RNA – i PATHWAY
RNA – i PATHWAY RNA – i PATHWAY
RNA – i PATHWAY
Shylesh M
 
RNAi, miRNA & siRNA
RNAi, miRNA & siRNARNAi, miRNA & siRNA
RNAi, miRNA & siRNA
sbryant89
 
Sigma xi test two
Sigma xi test twoSigma xi test two
Sigma xi test twocaavsresearchgroup
 
Si rna
Si rnaSi rna
Si rnaIshaqueAbdulla
 
Lecture5,6
Lecture5,6Lecture5,6
Lecture5,6Sucheta Tripathy
 
Woman's rare disease cured by lucky dna mutation
Woman's rare disease cured by lucky dna mutationWoman's rare disease cured by lucky dna mutation
Woman's rare disease cured by lucky dna mutation
Other Mother
 

More Related Content

What's hot

Short hairpin rna
Short hairpin rna Short hairpin rna
Short hairpin rna
Nagendra P
 
Terra (Telomeric repeat-containing RNA)
Terra (Telomeric repeat-containing RNA)Terra (Telomeric repeat-containing RNA)
Terra (Telomeric repeat-containing RNA)
sogand vahidi
 
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
QIAGEN
 
RNA interference
RNA interferenceRNA interference
RNA interference
Razavi Nader
 
Gene silencing and rnai
Gene silencing and rnaiGene silencing and rnai
Gene silencing and rnai
shiney chatak
 
The Role of Astroglia in the Development of Down Syndrome
The Role of Astroglia in the Development of Down SyndromeThe Role of Astroglia in the Development of Down Syndrome
The Role of Astroglia in the Development of Down Syndrome
Kathleen Allyson Harrison
 
RNA interference (RNAi):A therapeutic strategy for aquaculture
RNA interference (RNAi):A therapeutic strategy for aquacultureRNA interference (RNAi):A therapeutic strategy for aquaculture
RNA interference (RNAi):A therapeutic strategy for aquaculture
idrish123
 
RNAi interuption mechanism and application
RNAi interuption mechanism and applicationRNAi interuption mechanism and application
RNAi interuption mechanism and application
Sumeena Karki
 
RNA interference & its application
RNA interference & its applicationRNA interference & its application
RNA interference & its application
AkritiGaurav
 
Gene silencing
Gene silencingGene silencing
Gene silencing
Md. Dilshad karim
 
The future of treatments for PD psych research symposium poster 1_20162
The future of treatments for PD psych research symposium poster 1_20162The future of treatments for PD psych research symposium poster 1_20162
The future of treatments for PD psych research symposium poster 1_20162Morgan Stafford
 
RNA Interference (RNAi)
RNA Interference (RNAi)RNA Interference (RNAi)
RNA Interference (RNAi)
Suresh Antre
 
Receptor targeted polyplexes for pdna and sirna delivery emadi
Receptor targeted polyplexes for pdna and sirna delivery emadiReceptor targeted polyplexes for pdna and sirna delivery emadi
Receptor targeted polyplexes for pdna and sirna delivery emadi
Elaheh Emadi- Andani
 
Rna and truncated form in health and diseases
Rna and truncated form in health and diseasesRna and truncated form in health and diseases
Rna and truncated form in health and diseases
Gaurav Gupta
 
RNA – i PATHWAY
RNA – i PATHWAY RNA – i PATHWAY
RNA – i PATHWAY
Shylesh M
 
RNAi, miRNA & siRNA
RNAi, miRNA & siRNARNAi, miRNA & siRNA
RNAi, miRNA & siRNA
sbryant89
 

What's hot (20)

Short hairpin rna
Short hairpin rna Short hairpin rna
Short hairpin rna
 
Terra (Telomeric repeat-containing RNA)
Terra (Telomeric repeat-containing RNA)Terra (Telomeric repeat-containing RNA)
Terra (Telomeric repeat-containing RNA)
 
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
Circulating Biomarkers for Alzheimer's Disease: Neurodegenerative Disorders ...
 
RNA interference
RNA interferenceRNA interference
RNA interference
 
Gene silencing and rnai
Gene silencing and rnaiGene silencing and rnai
Gene silencing and rnai
 
The Role of Astroglia in the Development of Down Syndrome
The Role of Astroglia in the Development of Down SyndromeThe Role of Astroglia in the Development of Down Syndrome
The Role of Astroglia in the Development of Down Syndrome
 
RNA interference (RNAi):A therapeutic strategy for aquaculture
RNA interference (RNAi):A therapeutic strategy for aquacultureRNA interference (RNAi):A therapeutic strategy for aquaculture
RNA interference (RNAi):A therapeutic strategy for aquaculture
 
RNAi interuption mechanism and application
RNAi interuption mechanism and applicationRNAi interuption mechanism and application
RNAi interuption mechanism and application
 
Regulatory RNA
Regulatory RNARegulatory RNA
Regulatory RNA
 
RNA interference & its application
RNA interference & its applicationRNA interference & its application
RNA interference & its application
 
Gene silencing
Gene silencingGene silencing
Gene silencing
 
The future of treatments for PD psych research symposium poster 1_20162
The future of treatments for PD psych research symposium poster 1_20162The future of treatments for PD psych research symposium poster 1_20162
The future of treatments for PD psych research symposium poster 1_20162
 
RNA Interference (RNAi)
RNA Interference (RNAi)RNA Interference (RNAi)
RNA Interference (RNAi)
 
Hucis
HucisHucis
Hucis
 
Receptor targeted polyplexes for pdna and sirna delivery emadi
Receptor targeted polyplexes for pdna and sirna delivery emadiReceptor targeted polyplexes for pdna and sirna delivery emadi
Receptor targeted polyplexes for pdna and sirna delivery emadi
 
Rna and truncated form in health and diseases
Rna and truncated form in health and diseasesRna and truncated form in health and diseases
Rna and truncated form in health and diseases
 
RNA – i PATHWAY
RNA – i PATHWAY RNA – i PATHWAY
RNA – i PATHWAY
 
RNAi, miRNA & siRNA
RNAi, miRNA & siRNARNAi, miRNA & siRNA
RNAi, miRNA & siRNA
 
Sigma xi test two
Sigma xi test twoSigma xi test two
Sigma xi test two
 
Si rna
Si rnaSi rna
Si rna
 

Viewers also liked

Woman's rare disease cured by lucky dna mutation
Woman's rare disease cured by lucky dna mutationWoman's rare disease cured by lucky dna mutation
Woman's rare disease cured by lucky dna mutation
Other Mother
 
Genetics of Mitochondrial disorders
Genetics of Mitochondrial disordersGenetics of Mitochondrial disorders
Genetics of Mitochondrial disordersPramod Krishnan
 
Mutagen
MutagenMutagen
Mutagen
Harshraj Shinde
 
Mutation, Types and Causes, Chromosomal Variation in Number, Gene Mutation
Mutation, Types and Causes, Chromosomal Variation in Number, Gene MutationMutation, Types and Causes, Chromosomal Variation in Number, Gene Mutation
Mutation, Types and Causes, Chromosomal Variation in Number, Gene Mutation
Jan Del Rosario
 

Viewers also liked (8)

Lecture5,6
Lecture5,6Lecture5,6
Lecture5,6
 
Woman's rare disease cured by lucky dna mutation
Woman's rare disease cured by lucky dna mutationWoman's rare disease cured by lucky dna mutation
Woman's rare disease cured by lucky dna mutation
 
Radiation and chemical mutagens
Radiation and chemical mutagensRadiation and chemical mutagens
Radiation and chemical mutagens
 
Genetics of Mitochondrial disorders
Genetics of Mitochondrial disordersGenetics of Mitochondrial disorders
Genetics of Mitochondrial disorders
 
Mutagen
MutagenMutagen
Mutagen
 
Mutation
MutationMutation
Mutation
 
Mutation
MutationMutation
Mutation
 
Mutation, Types and Causes, Chromosomal Variation in Number, Gene Mutation
Mutation, Types and Causes, Chromosomal Variation in Number, Gene MutationMutation, Types and Causes, Chromosomal Variation in Number, Gene Mutation
Mutation, Types and Causes, Chromosomal Variation in Number, Gene Mutation
 

Similar to Founder mutation in Parkinson's disease presented on 12/10/08

Strathern JBC 2013 2689 slippage
Strathern JBC 2013 2689 slippageStrathern JBC 2013 2689 slippage
Strathern JBC 2013 2689 slippageJordan Irvin
 
notch signaling and acute leukemia
notch signaling and acute leukemianotch signaling and acute leukemia
notch signaling and acute leukemia
FereshteDorrazehi
 
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Sherman Jia
 
Neurological disorders arising from gene expression defects
Neurological disorders arising from gene expression defectsNeurological disorders arising from gene expression defects
Neurological disorders arising from gene expression defects
Denise Sheer
 
Targetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion diseaseTargetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion disease
Shahan Ullah
 
Targeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegenerationTargeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegeneration
Shahan Ullah
 
Chromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal clubChromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal club
AIIMS
 
Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)
Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)
Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)
Melbourne Bioanalytics
 
ShRNA-specific regulation of FMNL2 expression in P19 cells
ShRNA-specific regulation of FMNL2 expression in P19 cellsShRNA-specific regulation of FMNL2 expression in P19 cells
ShRNA-specific regulation of FMNL2 expression in P19 cells
YousefLayyous
 
A new specific and low cost technique to detect alk, ros, and ret rearrangeme...
A new specific and low cost technique to detect alk, ros, and ret rearrangeme...A new specific and low cost technique to detect alk, ros, and ret rearrangeme...
A new specific and low cost technique to detect alk, ros, and ret rearrangeme...
Christine Canet
 
Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...
Thermo Fisher Scientific
 
Jc, Ph-like acute lymphoblastic leukemia (ALL)
Jc, Ph-like acute lymphoblastic leukemia (ALL)Jc, Ph-like acute lymphoblastic leukemia (ALL)
Jc, Ph-like acute lymphoblastic leukemia (ALL)
Mohsin Maqbool
 
Infect. Immun.-2016-Jain-439-51
Infect. Immun.-2016-Jain-439-51Infect. Immun.-2016-Jain-439-51
Infect. Immun.-2016-Jain-439-51Neena Jain
 
Poster of Experimental Biology 2014, San Diego, CA
Poster of Experimental Biology 2014, San Diego, CAPoster of Experimental Biology 2014, San Diego, CA
Poster of Experimental Biology 2014, San Diego, CAStefano Martellucci
 
J. Biol. Chem.-2004-Rave-Harel-30287-97
J. Biol. Chem.-2004-Rave-Harel-30287-97J. Biol. Chem.-2004-Rave-Harel-30287-97
J. Biol. Chem.-2004-Rave-Harel-30287-97Hao Duong
 
Research articl e
Research articl eResearch articl e
Research articl e
gisa_legal
 

Similar to Founder mutation in Parkinson's disease presented on 12/10/08 (20)

Strathern JBC 2013 2689 slippage
Strathern JBC 2013 2689 slippageStrathern JBC 2013 2689 slippage
Strathern JBC 2013 2689 slippage
 
notch signaling and acute leukemia
notch signaling and acute leukemianotch signaling and acute leukemia
notch signaling and acute leukemia
 
Duzkale_2011_CLL biomarker LDOC1
Duzkale_2011_CLL biomarker LDOC1Duzkale_2011_CLL biomarker LDOC1
Duzkale_2011_CLL biomarker LDOC1
 
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
 
Neurological disorders arising from gene expression defects
Neurological disorders arising from gene expression defectsNeurological disorders arising from gene expression defects
Neurological disorders arising from gene expression defects
 
Alexia Chrysostomou (083707160)
Alexia Chrysostomou (083707160)Alexia Chrysostomou (083707160)
Alexia Chrysostomou (083707160)
 
Targetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion diseaseTargetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion disease
 
Calit2Poster
Calit2PosterCalit2Poster
Calit2Poster
 
Targeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegenerationTargeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegeneration
 
Chromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal clubChromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal club
 
Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)
Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)
Symptom/Metabolome-Directed Genomics of ME/CFS by Dr Neil McGregor (2017)
 
ShRNA-specific regulation of FMNL2 expression in P19 cells
ShRNA-specific regulation of FMNL2 expression in P19 cellsShRNA-specific regulation of FMNL2 expression in P19 cells
ShRNA-specific regulation of FMNL2 expression in P19 cells
 
A new specific and low cost technique to detect alk, ros, and ret rearrangeme...
A new specific and low cost technique to detect alk, ros, and ret rearrangeme...A new specific and low cost technique to detect alk, ros, and ret rearrangeme...
A new specific and low cost technique to detect alk, ros, and ret rearrangeme...
 
Gasparini_2014_02Thesis
Gasparini_2014_02ThesisGasparini_2014_02Thesis
Gasparini_2014_02Thesis
 
Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...
 
Jc, Ph-like acute lymphoblastic leukemia (ALL)
Jc, Ph-like acute lymphoblastic leukemia (ALL)Jc, Ph-like acute lymphoblastic leukemia (ALL)
Jc, Ph-like acute lymphoblastic leukemia (ALL)
 
Infect. Immun.-2016-Jain-439-51
Infect. Immun.-2016-Jain-439-51Infect. Immun.-2016-Jain-439-51
Infect. Immun.-2016-Jain-439-51
 
Poster of Experimental Biology 2014, San Diego, CA
Poster of Experimental Biology 2014, San Diego, CAPoster of Experimental Biology 2014, San Diego, CA
Poster of Experimental Biology 2014, San Diego, CA
 
J. Biol. Chem.-2004-Rave-Harel-30287-97
J. Biol. Chem.-2004-Rave-Harel-30287-97J. Biol. Chem.-2004-Rave-Harel-30287-97
J. Biol. Chem.-2004-Rave-Harel-30287-97
 
Research articl e
Research articl eResearch articl e
Research articl e
 

Recently uploaded

State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
Video Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the FutureVideo Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the Future
Alpen-Adria-Universität
 
Removing Uninteresting Bytes in Software Fuzzing
Removing Uninteresting Bytes in Software FuzzingRemoving Uninteresting Bytes in Software Fuzzing
Removing Uninteresting Bytes in Software Fuzzing
Aftab Hussain
 
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
Neo4j
 
GridMate - End to end testing is a critical piece to ensure quality and avoid...
GridMate - End to end testing is a critical piece to ensure quality and avoid...GridMate - End to end testing is a critical piece to ensure quality and avoid...
GridMate - End to end testing is a critical piece to ensure quality and avoid...
ThomasParaiso2
 
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
James Anderson
 
20240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 202420240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 2024
Matthew Sinclair
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
Introduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - CybersecurityIntroduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - Cybersecurity
mikeeftimakis1
 
20240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 202420240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 2024
Matthew Sinclair
 
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Albert Hoitingh
 
Free Complete Python - A step towards Data Science
Free Complete Python - A step towards Data ScienceFree Complete Python - A step towards Data Science
Free Complete Python - A step towards Data Science
RinaMondal9
 
By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024
Pierluigi Pugliese
 
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 daysPushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
Adtran
 
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfObservability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Paige Cruz
 
National Security Agency - NSA mobile device best practices
National Security Agency - NSA mobile device best practicesNational Security Agency - NSA mobile device best practices
National Security Agency - NSA mobile device best practices
Quotidiano Piemontese
 
Essentials of Automations: The Art of Triggers and Actions in FME
Essentials of Automations: The Art of Triggers and Actions in FMEEssentials of Automations: The Art of Triggers and Actions in FME
Essentials of Automations: The Art of Triggers and Actions in FME
Safe Software
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 

Recently uploaded (20)

State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
Video Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the FutureVideo Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the Future
 
Removing Uninteresting Bytes in Software Fuzzing
Removing Uninteresting Bytes in Software FuzzingRemoving Uninteresting Bytes in Software Fuzzing
Removing Uninteresting Bytes in Software Fuzzing
 
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
 
GridMate - End to end testing is a critical piece to ensure quality and avoid...
GridMate - End to end testing is a critical piece to ensure quality and avoid...GridMate - End to end testing is a critical piece to ensure quality and avoid...
GridMate - End to end testing is a critical piece to ensure quality and avoid...
 
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
 
20240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 202420240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 2024
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
Introduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - CybersecurityIntroduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - Cybersecurity
 
20240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 202420240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 2024
 
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
 
Free Complete Python - A step towards Data Science
Free Complete Python - A step towards Data ScienceFree Complete Python - A step towards Data Science
Free Complete Python - A step towards Data Science
 
By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024
 
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 daysPushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
 
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfObservability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
 
National Security Agency - NSA mobile device best practices
National Security Agency - NSA mobile device best practicesNational Security Agency - NSA mobile device best practices
National Security Agency - NSA mobile device best practices
 
Essentials of Automations: The Art of Triggers and Actions in FME
Essentials of Automations: The Art of Triggers and Actions in FMEEssentials of Automations: The Art of Triggers and Actions in FME
Essentials of Automations: The Art of Triggers and Actions in FME
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 

Founder mutation in Parkinson's disease presented on 12/10/08

  • 1. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson’s disease patients Presented by: Pearl Pfiester 12.10.08
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. Results Reported and novel coding mutations in the LRRK2 Roc and kinase domains. Symbols: red stars = putative pathogenic missense mutations detected in the Flanders-Belgian PD population (6 out of 10 carriers) green stars = novel rare variants (4 out of 10 carriers) yellow stars = known polymorphisms
  • 11. Data on protein conservation of all coding mutations in the LRRK2 Roc and kinase domains
  • 12.
  • 13.
  • 14.
  • 16. Results: Allele and Haplotype Analysis for p.R1441C
  • 17. Results for Novel Mutations
  • 18. Results for Novel Mutations
  • 19.
  • 20.